Companies you'll love to work for

Developer of a medical device platform designed to improve the treatment of hypervascular tumours. The company is developing novel radiopaque bland embolic and beta radiation emitting radiopaque Y-90 radioembolic agents that will help to improve targeting of tumour vascularity and tumour tissue, enabling doctors to help standardize, optimize and personalize these minimally invasive therapies.